Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) EPS (Weighted Average and Diluted) (2020 - 2025)

Historic EPS (Weighted Average and Diluted) for Adma Biologics (ADMA) over the last 6 years, with Q3 2025 value amounting to $0.15.

  • Adma Biologics' EPS (Weighted Average and Diluted) changed 0.0% to $0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.86, marking a year-over-year increase of 20714.29%. This contributed to the annual value of $0.81 for FY2024, which is 72486.49% up from last year.
  • Per Adma Biologics' latest filing, its EPS (Weighted Average and Diluted) stood at $0.15 for Q3 2025, which was down 0.0% from $0.14 recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' EPS (Weighted Average and Diluted) ranged from a high of $0.46 in Q4 2024 and a low of -$0.16 during Q1 2021
  • Its 5-year average for EPS (Weighted Average and Diluted) is $0.01, with a median of -$0.03 in 2023.
  • As far as peak fluctuations go, Adma Biologics' EPS (Weighted Average and Diluted) tumbled by 3333.33% in 2023, and later skyrocketed by 126702.49% in 2024.
  • Quarter analysis of 5 years shows Adma Biologics' EPS (Weighted Average and Diluted) stood at -$0.07 in 2021, then increased by 14.29% to -$0.06 in 2022, then crashed by 33.33% to -$0.08 in 2023, then soared by 674.79% to $0.46 in 2024, then tumbled by 67.38% to $0.15 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.15 in Q3 2025, compared to $0.14 in Q2 2025 and $0.11 in Q1 2025.